stockportfolio.pro
Arcus Biosciences, Inc. Net Income 2016–2025
Arcus Biosciences, Inc. (RCUS) annual net income by fiscal year, computed from SEC filings.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $-353.00M | -142.9% | -24.7% |
| FY 2024 | $-283.00M | -109.7% | +7.8% |
| FY 2023 | $-307.00M | -262.4% | -15.0% |
| FY 2022 | $-267.00M | -238.4% | -603.8% |
| FY 2021 | $53.00M | 13.8% | +143.1% |
| FY 2020 | $-123.00M | -157.7% | -45.2% |
| FY 2019 | $-84.71M | -564.7% | -70.8% |
| FY 2018 | $-49.59M | -593.7% | +6.6% |
| FY 2017 | $-53.08M | -3756.7% | -195.4% |
| FY 2016 | $-17.97M | — | — |
Source: Arcus Biosciences, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Arcus Biosciences, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeArcus Biosciences, Inc. — frequently asked questions
What is Arcus Biosciences, Inc.'s net income?
Arcus Biosciences, Inc. (RCUS) reported net income of $-353.00M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Arcus Biosciences, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.